Rare manifestations of Wegener's granulomatosis
To the Editor: Wegener' s granulomat t tosis (WG) is a necrotizing granulot t matous smalltvessel vasculitis. 1 The frequency of cardiac involvement in WG varies from 6 to 12 percent. 2 However, the occurrence of ascites and hemorrhagic effusion in WG were not reported in a MEDLINE search.
A 19tyeartold man was referred to Baqyatollah hospital with a hist t tory of fever and polyarthritis for two weeks. The patient presented with weight loss, productive cough, and hemoptysis. His temperature was 39ºC, heart rate 95/min and the respiratory rate was 28/min. A diffuse, coarse crackle was audible over both lungs. Severe joint inflamt t mation was noted. His chest Xtray showed multiple pulmonary infilt t tration ( Figure 1 ). He was treated for pulmonary abscess with clindat t mycin and ceftriaxone. The fever subsided gradually, but the polyart t thritis, tachycardia, and tachypnea continued. Ultrasound study of the abdomen (Fiugure 2), showed mild splenomegaly and ascites. Moderate pericardial effusion was noticed by echocardiography. In the chest CTt scan, multiple isodense masses were found. Because of his severe clinical condition a hightdose steroid was given. Subsequently, marked hemat t turia, granular casturia and proteint t uria developed.
CtANCA (cytoplasmic antit t neutrophil cytoplasmic antibody) was positive. Pericardial effusion presented with a bloody appearance and the WBC count was 15000/ mm 3 . Culture and PCR examinat t tions were negative. No organism grew in ascites fluid culture. The WBC count in ascitic fluid was 2500/mm 3 , with a PMN value of 75%. A CTtguided lung biopsy was performed. Multiple foci of necrot t sis and infiltration of macrophages and neutrophils were seen. The diagnosis of WG was made, and combination therapy of hightdose steroid with cyclophosphamide was prescribed. In a few days, his gent t eral condition began to show signs of improvement. All clinical, labot t ratory, and imaging abnormalities also improved. He was discharged after 30 days.
WG is a disease manifested by necrotizing granuloma of the upt t per respiratory tract, lung, and renal involvement 3 with a 5tyear survival rate approaching 95%. 2 Hemopericardium and ascites are a rare clinical picture not previously reported in WG. 
Morteza Rajai MD

What explains discrepant gend d der identity outcome in 46,XX individuals with 11dhydroxylase deficiency?
To The Editor: I read with great int t terest the report by BintAbbas et al 1 of two 46,XX siblings with 11t hydroxylase deficiency (11tOHD) raised male with divergent gender identity (GI) outcome in adolest t cence. The authors conclude "that the extent of external genitalia virt t ilization, particularly the degree of hypospadias, and not the duration or the level of prenatal and postnatal androgen exposure, is the main gent t der identity determinant" in 46,XX patients with CAH. I applaud the authors for having based their decit t sions for and against gendertreast t signment in these two siblings on a careful psychiatric evaluation with extensive counseling, but I am cont t cerned that their theoretical conclut t sions regarding the determinants of GI may lead some clinicians to problematic unifactorial decisions regarding gender assignment and retassignment.
Clearly, the "extent of external genitalia virilization" determines gender assignment at birth in newt t borns with normal genital developt t ment, and to a considerable extent also in newborns with ambiguous genitalia, especially when sophist t ticated diagnostic techniques are not readily accessible, as it is comt t mon in resourcetpoor communit t ties. However, the association of the degree of masculinization of the external genitalia with gender identity development is comparably weak, not only in 46,XY, but also in 46,XX individuals, and genitaltstat t tustbased gender assignment in int t fancy does not firmly determine GI outcome later. Otherwise we would not see gender dysphoria and pat t tienttdesired gender retassignment in 46,XX 21tOHDtCAH, which occurs−albeit with relatively low incidence−in both femalet and maletassigned patients. 2 In my readt t ing of the literature and my clinical experience with 46,XX CAH pat t tients raised female, patienttinitit t ated gender change to male occurs more frequently in patients born with Prader stage 3t4 (clitorot t phallus with hypospadias) than in patients born with Prader stage 5 (completely masculinized external genitalia). The existence of nontint t tersex patients with femalettotmale transsexualism who typically have entirely normal female genitalia also speaks against a determining role of the external genitalia for GI develt t opment.
So, which factors should one consider in explaining the different outcome in the two 11tOHD sibt t lings of BintAbbas et al? First of all, the remarkable difference between the siblings in genital development may indicate behaviorally relevant differences in androgen exposure of the developing brain. Given that the two siblings are offspring from the same parents, it is highly likely (albeit not absolutely certain) that the molecular abnormality of the 17tOHD gene is identical in both. Nevertheless, the high local androt t gen concentration required at the early critical period of genital dift t ferentiation for the formation of a penile urethra 3 was apparently not present in the older sibling, although later in development the androgen levels were high enough to promote substantial growth of a clitorophalt t lus. We do not know how late durt t ing the fetal development of this pat t tient the androgens increased to that level. The statement that the older sibling, in contrast to the younger one, "behaved as a female since early childhood", raises the quest t tion whether the systemic androgen level influencing the sexual different t tiation/masculinization of the brain during its hormonetsensitive period of prenatal development was lower in this sibling than in the younger one. Mammalian research has prot t vided ample evidence that both dose and duration of androgen exposure during the homonetsensitive pret or perinatal period of brain developt t ment affect later behavioral mascut t linization. This principle is likely to apply to humans as well. Research of my team in 46,XX individuals with 21tOHD CAH has clearly shown a dosetresponse relationship of synt t drome severity (which is associated with the degree of androgen excess) with gendertrelated behavior (GR), 4 and related research in both nont human primates and humans makes it likely that these GR effects are prit t marily prenatal rather than postnat t tal in origin. 5, 6 However, unlike the early critical period of genital differt t entiation, the hormonetsensitive pet t riod of sexual differentiation of the brain is much longer and extends far into the second half of pregnancy.
Our studies show considerable variability of GR in individuals with a given degree of CAH severt t ity, as one also sees it in nontintersex males and females, so that prenatal androgen production is certainly not the only biological factor that explains interindividual differences in behavioral masculinization. In addition, one has to consider potent t tial variations in systemic androgen metabolism, e.g., by aromatization, 7 or in androgen utilization due to ant t drogen receptor modulation by trit t nucleotide repeats in the androgen receptor gene, 8 also the possibility of CNStlimited variations of endot t crine processes such as production of neurosteroids and the action of steroid cotactivators and cotinhibit t tors, 9 ,10 and last but not least, cont t tributions from nontsteroid related genetic effects on temperament.
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Although psychosocial factors contribute to GR, 12 the markedly masculinized GR of 21tOHD CAH girls appears to be rather unt t responsive to parental gendertnort t malizing pressure, 13 
14 which makes it unlikely that the processes underlyt t ing the development of GI and GR are identical. Many individuals with a marked degree of gendertatypit t cal GR do not suffer from gender dysphoria, while others with a simit t lar degree do, and we still cannot pinpoint the etiological difference. Overall, it currently appears more likely that it is the confluence of a variety of interacting biological, sot t cial, and psychological factors rather than one prominent factor among these that pushes a given child or adolescent towards gender dysphot t ria or actual gendertreassignment. Thus, when deciding for the newt t born with a disorder of sex develt t opment on the gender assignment with optimal prognosis for stable GI development, we need to considt t er whether and to what extent the genital status at birth permits infert t ences on the androgenization of the brain, which varies considerably bet t tween syndromes, and to take into account all other known relevant factors including psychosocial and cultural ones. In cases of potential gender retassignment after infancy, a comprehensive evaluation of the patient' s gender status (GR, GI, and any indications of gender dysphot t ria) must be added. Medical chaperoning at a tertiary care hospital in Saudi Arabia: Prevalence and patient preference To the Editor: The prevalence of medical chaperoning and the related patient preference in Saudi Arabia (or other Islamic/Arab countries) have not been well documented. We examined these issues in the outtpatient clinics of a tertiary care hospital in Riyadh, Saudi Arabia, using a questionnaire that was comt t pleted during a personal interview. The study protocol, including vert t bal consent, was approved by the Research Ethics Committee of the institution. Two hundred thirtyt nine patients were approached and 224 (94%) agreed to participate (15 declined for undeclared reasons).
Two hundred and five particit t pants (2 males and 203 females, 92%) were seen by a physician of the opposite gender; 78 (38%) and 53 (26%) of which did not have a chaperone during the current medit t cal interview and exam, respectively. When not present, a chaperone was rarely offered by medical staff (2%) and never requested by the patient. Of the 224 participants, 72 (32%) and 48 (21%) recalled that a chapt t erone was absent during previous medical interviews and exams, ret t spectively. Table 1 shows chaperont t ing according to types of clinic and medical encounter. A significant association was found between the presence of a chaperone and clinic types for both interview and exam. There was also a significant assot t ciation between the presence of a chaperone and types of medical ent t counter for all clinics (P<0.0001) and in the case of Family Medicine and Polyclinics (P<0.0001). Of the 78 participants interviewed by a physician of the opposite gender in the absence of a chaperone, 77 (99%) were not offered a chapert t one by the hospital staff and none requested one. Similarly, of the 53 participants examined by a physit t cian of the opposite gender in the absence of a chaperone, 52 (98%) were not offered a chaperone and none requested one.
Ninetytone percent of chapert t ones during an interview were pat t tient relatives. Relatives and staff nurses contributed equally during an exam (38% and 39%, respect t tively). Fiftytsix percent and 21% of chaperones during an interview or exam, respectively, were males. Figure 1 depicts the preference of the 224 participants regarding chaperoning. Fiftytone percent and 85%, respectively, of the particit t pants who did not have a chaperone viewed the presence of a chaperone as commendable/preferred during interview and exam. The reasons most commonly cited for preferring a chaperone during an interview/ exam were religious (53%/ 63%), psychological (50%/ 49%), and sot t cial (22%/ 25% ) and for preferring not to have one were psychological (58%/ 38%) and privacy and confit t dentiality (52%/ 63%). The prevat t lence of chaperoning in our study (62% during an interview and 74% during an exam) is consistent with the results of previously reported studies in other parts of the world, which were mostly physiciantbased rather than patienttbased. In contrast to previous reports, 1t3 we found that family members comt t prised the majority of chaperones. This could be due to inadequate nursing staff or to the social norm that most female patients are usualt t ly accompanied by family members. Compared to previous reports, 4t6 our study showed a higher rate of patient preference for chaperoning, which is likely related to different social norms and religious values. Given this degree of preference, our observation that the patients who had a medical encounter without a chaperone were rarely offered a chaperone and never asked for one raises concerns about the training of hospital staff and the knowledge of patients about their rights. The results of the study may not be gent t eralizable to all patients in Saudi Arabia. We studied only outpatient clinics in one hospital. Further, although we aimed to study both male and female patients, our part t ticipants were 97% females.
Several bodies have developed guidelines and policies for chaperont t ing. 7t9 The standards of practice ret t garding chaperoning at KFSH&RC 
